Continental General Insurance CO Assertio Holdings, Inc. Transaction History

Continental General Insurance CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Apr 19, 2024	SELL	$1.02 - $2.57 $2.18 Million - $5.49 Million	-2,135,764 Closed	0 $0
Q3 2023 Apr 19, 2024	SELL	$2.52 - $5.69 $4.04 Million - $9.12 Million	-1,602,024 Reduced 42.86%	2,135,764 $5.46 Billion
Q2 2023 Apr 19, 2024	BUY	$5.0 - $7.66 $12.4 Million - $19 Million	2,486,751 Added 198.78%	3,737,788 $20.3 Billion
Q1 2023 Apr 19, 2024	BUY	$3.54 - $6.66 $4.43 Million - $8.33 Million	1,251,037 New	1,251,037 $7.97 Billion

31M

957K

38.5K

Ticker ASRT
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 48,178,200
Market Cap $40.5M
Description
Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...

Get notified when there are updates to the investment portfolio of Continental General Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Continental General Insurance CO with notifications on news.